SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-24-078981
Filing Date
2024-07-10
Accepted
2024-07-10 17:00:21
Documents
2
Period of Report
2024-07-08

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2419184-1_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2419184-1_3seq1.xml 3 1622
2 EXHIBIT 24 tm2419184d1_ex24.htm EX-24 5978
  Complete submission text file 0001104659-24-078981.txt   9197
Mailing Address 222 BERKELEY STREET 12TH FLOOR BOSTON MA 02116
Business Address 222 BERKELEY STREET 12TH FLOOR BOSTON MA 02116 857-264-4280
RHYTHM PHARMACEUTICALS, INC. (Issuer) CIK: 0001649904 (see all company filings)

IRS No.: 462159271 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O RHYTHM PHARMACEUTICALS 222 BERKELEY STREET, SUITE 1200 BOSTON MA 02116
Business Address
Garfield Alastair (Reporting) CIK: 0002027261 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38223 | Film No.: 241110478